Pages that link to "Q45941214"

The following pages link to Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge. (Q45941214):

Displaying 27 items.

• Is cognitive functioning impaired in methamphetamine users? A critical review (Q24606455) (← links)
• Potential adverse effects of amphetamine treatment on brain and behavior: a review (Q24657966) (← links)
• Methamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high‐dose methamphetamine administration (Q30443801) (← links)
• Alterations in the striatal dopamine system during intravenous methamphetamine exposure: effects of contingent and noncontingent administration (Q33602644) (← links)
• Methamphetamine reduces LTP and increases baseline synaptic transmission in the CA1 region of mouse hippocampus (Q33627747) (← links)
• BCG vaccine-induced neuroprotection in a mouse model of Parkinson's disease (Q33815568) (← links)
• Methamphetamine-induced short-term increase and long-term decrease in spatial working memory affects protein Kinase M zeta (PKMζ), dopamine, and glutamate receptors (Q34730006) (← links)
• Long-term protective effects of methamphetamine preconditioning against single-day methamphetamine toxic challenges (Q35107865) (← links)
• Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure (Q35287229) (← links)
• Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure. (Q35688532) (← links)
• Behavioral effects of chronic methamphetamine treatment in HIV-1 gp120 transgenic mice (Q36350707) (← links)
• Methamphetamine-induced dopamine terminal deficits in the nucleus accumbens are exacerbated by reward-associated cues and attenuated by CB1 receptor antagonism. (Q36457393) (← links)
• Development of stereotyped behaviors during prolonged escalation of methamphetamine self-administration in rats (Q36650613) (← links)
• Fast uptake and long-lasting binding of methamphetamine in the human brain: comparison with cocaine (Q37022467) (← links)
• Methamphetamine preconditioning: differential protective effects on monoaminergic systems in the rat brain (Q37168871) (← links)
• A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia (Q37212798) (← links)
• Extended-access, but not limited-access, methamphetamine self-administration induces behavioral and nucleus accumbens dopamine response changes in rats (Q37344068) (← links)
• Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion (Q37416424) (← links)
• Psychostimulant-related deaths among former inmates (Q37443482) (← links)
• Chronic Exposure to Methamphetamine Disrupts Reinforcement-Based Decision-Making in Rats (Q38662845) (← links)
• Ginsenoside Re protects methamphetamine-induced mitochondrial burdens and proapoptosis via genetic inhibition of protein kinase C δ in human neuroblastoma dopaminergic SH-SY5Y cell lines (Q38927155) (← links)
• Bacillus Calmette-Guerin vaccine-mediated neuroprotection is associated with regulatory T-cell induction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease (Q44578009) (← links)
• Long-term methamphetamine administration in the vervet monkey models aspects of a human exposure: brain neurotoxicity and behavioral profiles. (Q46204594) (← links)
• Methamphetamine influences on recognition memory: comparison of escalating and single-day dosing regimens (Q46391823) (← links)
• Differential neurochemical consequences of an escalating dose-binge regimen followed by single-day multiple-dose methamphetamine challenges (Q46772970) (← links)
• Chronic voluntary oral methamphetamine induces deficits in spatial learning and hippocampal protein kinase Mzeta with enhanced astrogliosis and cyclooxygenase-2 levels. (Q52316669) (← links)
• Evaluating Exercise as a Therapeutic Intervention for Methamphetamine Addiction-Like Behavior. (Q55286284) (← links)